Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report

Purpose: Dapagliflozin has been used extensively in patients with type 2 diabetes mellitus (T2DM). However, due to the potential diabetic ketoacidosis (DKA) risk of dapagliflozin, its use in type 1 diabetes mellitus (T1DM) is limited. Here, we reported an obese patient with T1DM and inadequate glyce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yan, Hu, Weiting, Yan, Qun, Feng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223692/
https://www.ncbi.nlm.nih.gov/pubmed/37241059
http://dx.doi.org/10.3390/medicina59050827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223692/
https://www.ncbi.nlm.nih.gov/pubmed/37241059
http://dx.doi.org/10.3390/medicina59050827

Ejemplares similares